$1.92 Billion is the total value of SABBY MANAGEMENT, LLC's 287 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ISHARES RUSSELL 2000 ETFput | $156,359,000 | – | 13,600 | +100.0% | 8.16% | – | |
| New | MONSANTO COcall | $55,159,000 | – | 5,334 | +100.0% | 2.88% | – | |
| New | PFIZER INCcall | $35,210,000 | – | 10,000 | +100.0% | 1.84% | – | |
| New | DEXCOM INCput | $33,430,000 | – | 4,214 | +100.0% | 1.74% | – | |
| New | ABBOTT LABSput | $19,655,000 | – | 5,000 | +100.0% | 1.03% | – | |
| New | TEVA PHARMACEUTICAL INDUSTRIES LTDcall | $18,173,000 | – | 3,618 | +100.0% | 0.95% | – | |
| New | TESARO INCcall | $18,138,000 | – | 2,158 | +100.0% | 0.95% | – | |
| New | SHIRE PLCcall | $12,849,000 | – | 698 | +100.0% | 0.67% | – | |
| New | SHIRE PLCput | $12,849,000 | – | 698 | +100.0% | 0.67% | – | |
| New | SPDR GOLD TRUSTcall | $12,652,000 | – | 1,000 | +100.0% | 0.66% | – | |
| New | SAGE THERAPEUTICS INCput | $10,533,000 | – | 3,496 | +100.0% | 0.55% | – | |
| ABT | New | ABBOTT LABS | $10,405,000 | – | 264,700 | +100.0% | 0.54% | – |
| New | DEXCOM INCcall | $9,361,000 | – | 1,180 | +100.0% | 0.49% | – | |
| New | IONIS PHARMACEUTICALS INCcall | $8,384,000 | – | 3,600 | +100.0% | 0.44% | – | |
| New | ALKERMES PLCcall | $7,930,000 | – | 1,335 | +100.0% | 0.41% | – | |
| New | CORSICANTO LTD 3.5%note | $7,877,000 | – | 7,756,000 | +100.0% | 0.41% | – | |
| ONS | New | ONCOBIOLOGICS INC | $7,035,000 | – | 2,068,968 | +100.0% | 0.37% | – |
| New | LION BIOTECHNOLOGIES INCput | $6,096,000 | – | 7,526 | +100.0% | 0.32% | – | |
| BPTH | New | BIO PATH HOLDINGS INC | $5,947,000 | – | 2,988,295 | +100.0% | 0.31% | – |
| New | ALNYLAM PHARMACEUTICALS INCcall | $5,477,000 | – | 987 | +100.0% | 0.29% | – | |
| SHPG | New | SHIRE PLC | $5,440,000 | – | 29,550 | +100.0% | 0.28% | – |
| New | EXPRESS SCRIPTS HOLDING CO.put | $5,041,000 | – | 665 | +100.0% | 0.26% | – | |
| New | TEVA PHARMACEUTICAL INDUSTRIES LTDput | $5,023,000 | – | 1,000 | +100.0% | 0.26% | – | |
| CYTX | New | CYTORI THERAPEUTICS INC | $4,110,000 | – | 1,966,708 | +100.0% | 0.21% | – |
| CVM | New | CEL SCI CORP | $3,755,000 | – | 8,163,816 | +100.0% | 0.20% | – |
| New | NEUROCRINE BIOSCIENCES INCcall | $3,695,000 | – | 813 | +100.0% | 0.19% | – | |
| New | ALNYLAM PHARMACEUTICALS INCput | $3,363,000 | – | 606 | +100.0% | 0.18% | – | |
| DRRX | New | DURECT CORP | $3,099,000 | – | 2,540,278 | +100.0% | 0.16% | – |
| ILMN | New | ILLUMINA INC | $2,808,000 | – | 20,000 | +100.0% | 0.15% | – |
| EDAP | New | EDAP TMS S Aadr | $2,804,000 | – | 847,225 | +100.0% | 0.15% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC. | $2,465,000 | – | 779,926 | +100.0% | 0.13% | – |
| OPGN | New | OPGEN INC | $2,470,000 | – | 1,625,000 | +100.0% | 0.13% | – |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $2,431,000 | – | 623,317 | +100.0% | 0.13% | – |
| New | LA JOLLA PHARMACEUTICAL COcall | $2,333,000 | – | 1,458 | +100.0% | 0.12% | – | |
| New | ABBOTT LABScall | $2,182,000 | – | 555 | +100.0% | 0.11% | – | |
| CUR | New | NEURALSTEM INC | $1,893,000 | – | 6,503,800 | +100.0% | 0.10% | – |
| New | MOMENTA PHARMACEUTICALS INCcall | $1,875,000 | – | 1,736 | +100.0% | 0.10% | – | |
| CPST | New | CAPSTONE TURBINE CORP | $1,845,000 | – | 1,336,901 | +100.0% | 0.10% | – |
| New | OPHTHOTECH CORPcall | $1,842,000 | – | 361 | +100.0% | 0.10% | – | |
| New | GW PHARMACEUTICALS PLCcall | $1,575,000 | – | 172 | +100.0% | 0.08% | – | |
| New | VANDA PHARMACEUTICALS INCcall | $1,555,000 | – | 1,390 | +100.0% | 0.08% | – | |
| New | LEXICON PHARMACEUTICALS INCput | $1,405,000 | – | 979 | +100.0% | 0.07% | – | |
| New | OPKO HEALTH INCcall | $1,393,000 | – | 1,491 | +100.0% | 0.07% | – | |
| New | PUMA BIOTECHNOLOGY INCcall | $1,364,000 | – | 458 | +100.0% | 0.07% | – | |
| EXPR | New | EXPRESS SCRIPTS HOLDING CO. | $1,242,000 | – | 16,386 | +100.0% | 0.06% | – |
| SCYX | New | SCYNEXIS INC | $1,243,000 | – | 572,928 | +100.0% | 0.06% | – |
| New | DERMIRA INCcall | $1,205,000 | – | 412 | +100.0% | 0.06% | – | |
| TEAR | New | TEARLAB CORP. | $1,205,000 | – | 1,882,347 | +100.0% | 0.06% | – |
| New | AERIE PHARMACEUTICALS INCcall | $1,186,000 | – | 674 | +100.0% | 0.06% | – | |
| DNAI | New | PRONAI THERAPEUTICS INC | $1,174,000 | – | 590,011 | +100.0% | 0.06% | – |
| NVAX | New | NOVAVAX INC | $1,038,000 | – | 142,726 | +100.0% | 0.05% | – |
| EYEG | New | EYEGATE PHARMACEUTICALS INC | $1,002,000 | – | 386,940 | +100.0% | 0.05% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $972,000 | – | 435,957 | +100.0% | 0.05% | – |
| IMMU | New | IMMUNOMEDICS INC | $986,000 | – | 425,000 | +100.0% | 0.05% | – |
| APHB | New | AMPLIPHI BIOSCIENCES CORP | $951,000 | – | 613,782 | +100.0% | 0.05% | – |
| GNVC | New | GENVEC INC | $931,000 | – | 1,625,435 | +100.0% | 0.05% | – |
| WINT | New | WINDTREE THERAPEUTICS INC | $866,000 | – | 448,509 | +100.0% | 0.04% | – |
| DXTRQ | New | DEXTERA SURGICAL INC. | $868,000 | – | 482,000 | +100.0% | 0.04% | – |
| CASC | New | CASCADIAN THERAPEUTICS INC | $815,000 | – | 864,402 | +100.0% | 0.04% | – |
| CYTXW | New | CYTORI THERAPEUTICS INC*w | $793,000 | – | 1,004,065 | +100.0% | 0.04% | – |
| New | CELGENE CORPput | $759,000 | – | 77 | +100.0% | 0.04% | – | |
| New | HCA HOLDINGS INCput | $770,000 | – | 100 | +100.0% | 0.04% | – | |
| MDGN | New | MEDGENICS INC | $770,000 | – | 138,777 | +100.0% | 0.04% | – |
| AST | New | ASTERIAS BIOTHERAPEUTICS INC | $741,000 | – | 308,909 | +100.0% | 0.04% | – |
| KTOV | New | KITOV PHARMACEUTICALS HOLDINGSadr | $725,000 | – | 232,524 | +100.0% | 0.04% | – |
| OVAS | New | OVASCIENCE INC | $704,000 | – | 135,101 | +100.0% | 0.04% | – |
| PARNF | New | PARNELL PHARMACEUTICALS HOLDINGS LTD | $635,000 | – | 389,400 | +100.0% | 0.03% | – |
| ADMA | New | ADMA BIOLOGICS INC | $595,000 | – | 100,000 | +100.0% | 0.03% | – |
| New | MIRATI THERAPEUTICS INC | $586,000 | – | 107,235 | +100.0% | 0.03% | – | |
| New | RADIUS HEALTH INCcall | $577,000 | – | 157 | +100.0% | 0.03% | – | |
| New | HEARTWARE INTERNATIONAL INCput | $514,000 | – | 89 | +100.0% | 0.03% | – | |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $502,000 | – | 90,362 | +100.0% | 0.03% | – |
| New | RADIUS HEALTH INCput | $441,000 | – | 120 | +100.0% | 0.02% | – | |
| New | IPATH S&P 500 VIXcall | $414,000 | – | 300 | +100.0% | 0.02% | – | |
| NERV | New | MINERVA NEUROSCIENCES INC | $388,000 | – | 38,000 | +100.0% | 0.02% | – |
| New | RIGEL PHARMACEUTICALS INCcall | $375,000 | – | 1,684 | +100.0% | 0.02% | – | |
| New | MEDICINES COput | $336,000 | – | 100 | +100.0% | 0.02% | – | |
| ACRS | New | ACLARIS THERAPEUTICS INC | $292,000 | – | 15,812 | +100.0% | 0.02% | – |
| MDVN | New | MEDIVATION INC | $271,000 | – | 4,500 | +100.0% | 0.01% | – |
| New | MEDIVATION INCput | $271,000 | – | 45 | +100.0% | 0.01% | – | |
| New | ACORDA THERAPEUTICS INCput | $255,000 | – | 100 | +100.0% | 0.01% | – | |
| New | TENET HEALTHCARE CORPcall | $224,000 | – | 81 | +100.0% | 0.01% | – | |
| MDCO | New | MEDICINES CO | $235,000 | – | 7,000 | +100.0% | 0.01% | – |
| STAF | New | STAFFING 360 SOLUTIONS INC | $216,000 | – | 136,583 | +100.0% | 0.01% | – |
| ONSIW | New | ONCOBIOLOGICS INC*w | $209,000 | – | 426,184 | +100.0% | 0.01% | – |
| New | ALCOBRA LTDput | $184,000 | – | 409 | +100.0% | 0.01% | – | |
| ATHX | New | ATHERSYS INC SHS | $199,000 | – | 91,746 | +100.0% | 0.01% | – |
| ONSIZ | New | ONCOBIOLOGICS INC*w | $196,000 | – | 436,923 | +100.0% | 0.01% | – |
| New | MOMENTA PHARMACEUTICALS INCput | $172,000 | – | 159 | +100.0% | 0.01% | – | |
| New | NATERA INCcall | $174,000 | – | 144 | +100.0% | 0.01% | – | |
| New | SERES THERAPEUTICS INCcall | $142,000 | – | 49 | +100.0% | 0.01% | – | |
| ADXS | New | ADVAXIS INC | $113,000 | – | 14,000 | +100.0% | 0.01% | – |
| New | DURECT CORPcall | $94,000 | – | 770 | +100.0% | 0.01% | – | |
| AKBA | New | AKEBIA THERAPEUTICS INCcall | $75,000 | – | 100 | +100.0% | 0.00% | – |
| New | ATHERSYS INC SHSput | $49,000 | – | 225 | +100.0% | 0.00% | – | |
| GALE | New | GALENA BIOPHARMA INC | $53,000 | – | 113,530 | +100.0% | 0.00% | – |
| VKTXW | New | VIKING THERAPEUTICS INC*w | $51,000 | – | 176,113 | +100.0% | 0.00% | – |
| CBMX | New | COMBIMATRIX CORP. | $41,000 | – | 14,391 | +100.0% | 0.00% | – |
| New | TENAX THERAPEUTICS INCput | $43,000 | – | 169 | +100.0% | 0.00% | – | |
| New | INFINITY PHARMACEUTICALS INCput | $30,000 | – | 225 | +100.0% | 0.00% | – | |
| INFI | New | INFINITY PHARMACEUTICALS INC | $30,000 | – | 22,500 | +100.0% | 0.00% | – |
| New | INFINITY PHARMACEUTICALS INCcall | $22,000 | – | 167 | +100.0% | 0.00% | – | |
| New | MAST THERAPEUTICS INCput | $17,000 | – | 369 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 40 | Q2 2024 | 49.1% |
| ISHARES TR | 38 | Q2 2024 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| ISHARES TR | 20 | Q2 2024 | 12.7% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyngn Inc. | January 04, 2024 | 5,322,048 | 10.0% |
| iBio, Inc. | January 04, 2024 | 200,303 | 10.0% |
| InMed Pharmaceuticals Inc. | January 04, 2024 | 524,972 | 10.0% |
| Phunware, Inc. | January 04, 2024 | 10,006,584 | 5.9% |
| TREASURE GLOBAL INC | January 04, 2024 | 5,338,587 | 10.0% |
| Arcadia Biosciences, Inc. | January 03, 2024 | 97,305 | 8.8% |
| Bluejay Diagnostics, Inc. | January 03, 2024 | 177,513 | 10.0% |
| Fangdd Network Group Ltd. | January 03, 2024 | 600,427 | 10.0% |
| GlucoTrack, Inc. | January 03, 2024 | 2,087,130 | 10.0% |
| LIPELLA PHARMACEUTICALS INC. | January 03, 2024 | 579,814 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-04 |
| 4 | 2024-09-03 |
| 4 | 2024-08-30 |
| 4 | 2024-08-28 |
| 4 | 2024-08-26 |
| 4 | 2024-08-22 |
| 4 | 2024-08-20 |
| 4 | 2024-08-16 |
| 13F-HR | 2024-08-14 |
| 4 | 2024-08-14 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.